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Background
The risks of electronic cigarette are a subject of uncer-
tainty. The study was designed to assess the acute effect of
smoking an e- cigarette on vital signs, clinical symptoms
and exhaled markers.
Materials and methods
Sixty two participants (32 men) with a mean age of
45.43 years have been recruited. Sixteen smokers were
suffered by COPD, 12 smokers by asthma, 24 smokers
had no overt airways disease. All were current smokers
with a long smoking history. A group of 10 non-smokers
was also included. The same brand of e-cig was used for
10 min inhaled 11mg. Clinical symptoms, vital signs,
-heart rate, oxygen saturation (SpO2) and exhaled CO,
was assessed pre and post the e-cig use.
Results
Cough and sore throat were presented in both groups,
of non-smokers and smokers following the e-cig smok-
ing. Sore throat and cough were reported by 90% of
asthmatics and 63% of COPD. A significant increase in
heart rate (p<0.05) with palpitations was also noted with
a decrease in SpO2 mainly smokers (p<0.05). An inter-
esting finding was the significant increase in exhaled CO
in the group of non-smokers (p<0.05). Smoking an e-cig
was acceptable and gave a feeling of pleasure in a low
number of participants (18% of smokers, 27% of smo-
kers with asthma and 43% in smokers with COPD).
There were also a 12% of non smokers who have easily
accepted its use.
Conclusions
Our study shows that even a single use of an e-cigarette
increased heart rate and symptoms like cough and sore
throat. Claims that electronic cigarettes can help smo-
kers quit need to be backed up by clinical studies and
toxicity analyses and operate within the proper regula-
tory framework.
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